$0.00
DasaPro™ (Dasatinib)
$64.19
Senolytic agent for removing senescent cells
Dasatinib is approved as a cancer medication, but recent attention has been focused on its ability to act as a senolytic; that is an agent that can remove ‘dead’ (senescent) cells within the body by inducing a process known as autophagy. There is no doubt that Dasatinib represents the cutting-edge in anti-aging medicine, perhaps even experimental in some respects, but hardcore enthusiasts are aware that senolytics are presently a major focus of research.999 in stock
Product Usage
Statements and products on this site have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Your continued use of this site implies understanding and acceptance of these conditions.
